The duo plan to establish a global center of excellence in theranostics, taking advantage of Siemens’ state-of-the-art technology and software to advance the use of radiopharmaceuticals in cancer care.
The Impella CP heart pump is being used more and more to treat cardiogenic shock, and the benefits are clear. For many older patients, however, the technology seem to fall short.
Two separate groups have published new research comparing early AVR with clinical surveillance for the treatment of asymptomatic severe aortic stenosis. Overall, the two groups found, early treatment was associated with multiple benefits—and no added risk of harm.
Researchers involved in its development are hopeful that the scanner could eventually lead to improved outcomes in cancer patients who require surgery to remove malignant tissue.
The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses machine learning to review medical images that have been collected over a prolonged period.
These animals are virtually indestructible and have long outlived the dinosaurs due to their ability to withstand extreme cold, heat, natural disasters and even cosmic radiation.
The algorithm has an edge over standard black box-style artificial intelligence applications because providers are able to see how it reaches conclusions.
It can be difficult to deliver targeted therapy to the brain due to its protective barrier, which only allows certain nutrients and oxygen to pass through.
